The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?

Ezat, Ahmed A; Abduljalil, Jameel M; Elghareib, Ahmed M; Samir, Ahmed; Elfiky, Abdo A

Ezat, Ahmed A; Abduljalil, Jameel M; Elghareib, Ahmed M; Samir, Ahmed; Elfiky, Abdo A.

Affiliation

Ezat AA; Department of Biophysics, Faculty of Science, Cairo University, Giza, Egypt.
Abduljalil JM; Department of Biological Sciences, Faculty of Applied Sciences, Thamar University, Dhamar, Yemen.
Elghareib AM; Department of Biophysics, Faculty of Science, Cairo University, Giza, Egypt.
Samir A; Department of Biophysics, Faculty of Science, Cairo University, Giza, Egypt.
Elfiky AA; Department of Biophysics, Faculty of Science, Cairo University, Giza, Egypt.

Expert Opin Drug Discov ; 18(5): 551-561, 2023 05.

Article in En | MEDLINE | ID: mdl-37032577

Subject(s)

Dermatologic Agents; Mpox (monkeypox); Humans; Antiviral Agents/pharmacology; Drug Repositioning; Cidofovir; Benzamides

Key words

MPXV; Mpox virus; drug repurposing; molecular dynamics simulation; structural bioinformatics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mpox (monkeypox) / Dermatologic Agents Limits: Humans Language: En Journal: Expert Opin Drug Discov Year: 2023 Document type: Article Affiliation country: Egypt Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google